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Abstract
Background: There are various definitions and diagnostic criteria for dementia, leading to discrepancies in
case ascertainment in both clinical practice and research. We reviewed the different definitions, approaches
and measurements used to operationalize dementia in health care studies in German nursing homes with the
aim of discussing the implications of different approaches.
Methods: We conducted a systematic search of the MEDLINE and CINAHL databases to identify pre-2016
studies conducted in German nursing homes that focused on residents with dementia or cognitive impairment. In- or
exclusion of studies were consented by all authors; data extraction was independently carried out by 2 authors (RP, SJ).
The studies’ sampling methods were compared with respect to their inclusion criteria, assessment tools and methods
used to identify the study population.
Results: We summarized case ascertainment methods from 64 studies. Study participants were identified based on
a diagnosis that was evaluated during the study, or a recorded medical dementia diagnosis, or a recorded medical
diagnosis either with additional cognitive screenings or using screening tests exclusively. The descriptions of the
diagnostics that were applied to assess a diagnosis of dementia were not fully transparent in most of the studies
with respect to either a clear reference definition of dementia or applied diagnostic criteria. If reported, various
neuropsychological tests were used, mostly without a clear rationale for their selection.
Conclusion: Pragmatic considerations often determine the sampling strategy; they also may explain the variances we
detected in the different studies. Variations in sampling methods impede the comparability of study results. There is a
need to consent case ascertainment strategies in dementia studies in health service research in nursing homes. These
strategies should consider resource constraints and ethical issues that are related to the vulnerable population of
nursing home residents. Additionally, reporting about dementia studies in nursing homes need to be improved. If a
diagnosis cannot be evaluated based on either ICD or DSM criteria, the study population may not be reported as
having dementia. If a diagnosis is evaluated based on ICD or DSM criteria within the study, there is a need for more
transparency of the diagnostic process.
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Background
Health care service research aims to evaluate care strat-
egies by obtaining an understanding of the causal factors
in improving dementia-related outcomes for individuals
living in nursing homes [1]. It is self-evident that a valid
method to ascertain a case is a prerequisite for any study
[2]. Case ascertainment strategies must rely on an estab-
lished definition, and diagnostic criteria must be both
valid and feasible to conduct.
Dementia may be defined as a clinical syndrome of
mental capacity characterized by a substantial global
decline in cognitive function that is not attributable to
altered consciousness; it consists of a combination of
symptoms attributable to various causes or pathological
events [3]. Following the Diagnostic and Statistical Man-
ual (DSM) 5th edition [4], dementia is subsumed under
the entity of neurocognitive disorders (NCD). The diag-
nostic criteria for NCD are as follows:
i. Evidence of a significant cognitive decline from a
previous level of performance in one or more
cognitive domains (complex attention, executive
function, learning and memory, language,
perceptual-motor or social cognition)
ii. The cognitive deficits interfere with independence in
everyday activities (present in major NCD but not in
mild NCD)
iii. The cognitive deficits do not occur exclusively in the
context of a delirium
iv. The cognitive deficits are not better explained by
another mental disorder
Evidence for the cognitive decline should be based on
concerns from the individual patient, a knowledgeable
informant, or the clinician regarding the presence of a
significant decline in cognitive function and a substantial
impairment in cognitive performance; ideally, this evidence
will be documented by standardized neuropsychological
testing. The DSM-V manual notes that both concern and
objective evidence are required to establish a diagnosis
because they are complementary. If alterations in cogni-
tion are only tested utilizing objective measures, a disorder
may be underdiagnosed in individuals who demonstrate
high-functioning performance and score in the “normal”
range but are still substantially impaired relative to their
baseline performance. On the other hand, an exclusive
reliance on subjective symptoms may result in underdiag-
nosing individuals who deny or fail to express their
impairments. In either case, it is essential to interpret
results in comparison with the individual patients’ prior
performance.
The International Classification of Diseases (ICD) de-
fines dementia as a decline in both memory and other
cognitive abilities such as deterioration in judgment and
thinking or the general processing of information. The
decline in memory and cognitive abilities should be ob-
jectively verified by obtaining a reliable history from an
informant and supplemented by neuropsychological tests
or quantified cognitive assessments. The diagnosis of mild
impairment is based on the degree of memory loss that
interferes with everyday activities. A diagnosis of dementia
requires, in addition to the previously mentioned symp-
toms for mild impairment, a decline in emotional control
or motivation, changes in social behavior, and the absence
of delirium. Furthermore, the described symptoms must
be present for at least 6 months [5].
The diagnostic process follows two steps, starting with
the initial recognition of the dementia syndrome and
ending with the specification of an etiological subtype.
The diagnostic criteria for each of the subtypes are spe-
cified in the DSM-V, ICD-10 [4, 5] and publications
from different disease-related societies or national insti-
tutes (e.g., the National Institute of Neurological and
Communicative Disorders and Stroke, NINCDS) [6–10].
The subtype differentiation may require biomarker diag-
nostics such as genetic, blood and liquor testing or diverse
imaging procedures.
For more than 3 decades, the history of classification
systems for mental disorders has reflected both many
changes and a relative emphasis on phenomenology, eti-
ology, and course as defining features. When the DSM-
III’s (1980) explicit diagnostic criteria were introduced
(Feighner-criteria), several revisions followed: the DSM-
III-R (revision) in 1987, the DSM-IV in 1994, and the
DSM-V in 2013. The ICD introduced diagnostic criteria
in its revised version 9, ICD-9-CM (for clinical modifica-
tion). Every revision aimed both to reduce inconsistencies
and to improve clarity and precision. Different versions
included changes in the classification, diagnostic criteria
sets, and descriptive texts [11].
Dementia diagnoses pose several challenges. First, the
lack of valid biomarkers forces healthcare providers to
diagnose dementia based on the presence of specific
symptoms and the elimination of other conditions with
similar symptoms. To arrive at a clinical diagnosis of de-
mentia, a combination of basic assessments,—including
physical, psychopathological and basic neuropsycho-
logical examinations—are recommended [12, 13]. For
the basic neuropsychological diagnosis, different short
screening tests such as the Mini Mental Status Examin-
ation (MMSE) [14, 15], the DemTect [16] and the
Clock Drawing Test [17] are recommended. In clinical
practice, these tests should be administered to every
patient with dementia or suspected dementia on a
regular basis both to quantify cognitive impairments
and to enable providers to supervise the progression
of the disease. Comprehensive neuropsychological diag-
nostics are necessary either if diagnostic findings are not
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congruent in the early stage of dementia or if an etio-
logical classification is required. A dementia diagnosis
should not be based solely on one neuropsychological
test but instead must be based on both behavioral
symptoms and impairment assessments related to daily
function. Additionally, blood tests and imaging diag-
nostics should be conducted to assure both the diagno-
sis and its etiology [18].
The reliability, validity and utility of the new diagnos-
tic criteria have discussed by clinicians and researchers
since the date of their release; furthermore, a consensus
about how to best diagnose dementia has still not been
found [19, 20]. One result of this controversy is the
methodological differences in epidemiological studies
that lead to discrepancies in case ascertainment and
varying incidence and prevalence rates [3, 21]. Another
limitation of the generalizability of study results on
dementia in nursing homes originates from the meth-
odological difficulties of assessing the disease in the
oldest old population. The normative data necessary to
determine “impairment” for this population are lacking
and therefore, aging is constitutionally associated with a
decline in both cognition and function. Consequently,
pathological processes are difficult to distinguish from
normal aging; in addition, alterations in function and
sensory impairments may both affect subjects’ cognitive
performance and limit an accurate assessment [20].
The quality of a dementia diagnosis in German nurs-
ing homes is suboptimal: many studies of nursing home
residents show both vast inaccuracies and diagnostics
that do not conform to either the ICD or the DSM.
Studies from Germany show that between 30 and 40 %
of people with dementia living in nursing homes are not
accurately diagnosed; for these residents, either an etio-
logical differentiation is missing or there is an inappro-
priate diagnosis [22–24]. Inaccurate diagnosis has also
been found in studies from the United States, Norway,
Israel and Ireland [25–29].
Nursing home research is challenged by inaccurate
recorded diagnoses. Ignoring inconsistencies in a re-
corded dementia diagnosis may provoke misclassifica-
tions, bias selection and confound study results [30].
However, the evaluation of a diagnosis within a study is
resource-intensive and may be ethically questionable be-
cause the diagnosis process is reported as burdensome
and stigmatizing [31, 32].
Researchers must develop a sampling strategy that
eliminates inconsistencies while remaining both reliable
and practicable. We assume that in the past, researchers
defined dementia differently and applied different methods
to identify residents with dementia in nursing homes.
Therefore, we investigated the methods used to define
dementia and to identify people with dementia in health
services research. Although we assume that the delineated
problem is obvious in various countries, we limited the
scope of our study to research undertaken in a single
country (Germany). In Germany, physicians are not con-
stantly present in nursing homes, and nurses are not
allowed to assist in diagnostic procedures; resources for
dementia diagnostics in primary care are scarce [33];
hence, diagnostics are often superficial, performed rapidly
and lacking recommended measures [34, 35]. Due to the
free choice of medical practitioners that is guaranteed by
law in Germany, residents within one nursing home may
be cared for by different practitioners, making it difficult
for researchers to reconstruct the diagnostic procedures
that were applied by various medical doctors. These con-
ditions require a carefully considered sampling strategy.
The narrowed focus on one country ensures the compar-
ability of the studies because the nursing-home conditions
are identical. This allows a synthesis and comparison of
the various methods used in the included studies.
Because cognitive impairment (CI) is the leading symp-
tom in dementia and the conditions “dementia” and “CI”
are sometimes used interchangeably in scientific publica-
tions, the scope of our review encompasses studies that do
not exclusively focus on residents with dementia but in-
stead include residents with CI. Provided we found differ-
ences, we discuss the implications of different methods on
the generalizability and comparability of the study findings.
The following research questions were addressed:
How is dementia defined and measured in health
services research studies in German nursing homes?
Which implications can be derived for health services
research in nursing homes?
Based on the results, we discuss the implications of
the different methods and suggest principles to guide
future studies.
Methodology of the review
Compared to systematic reviews that aim to answer ques-
tions about the effectiveness of clinical procedures, there
are few well-defined tools and processes for methodological
reviews; not all items of the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines are applicable (see PRISMA checklist in the Additional
file 1: Table S1) [36]. Unlike a traditional Cochrane-style re-
view, Lilford and colleagues [36] recommend methodo-
logical reviewers not to obtain a thorough collection of
studies, but to ensure a wide search that provides an over-
view of the topic. They also recommend various safeguards
to reduce potential bias, such as multi-disciplinary teams
and peer reviewing of the final report. The methods applied
in this review consider these recommendations.
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Literature search strategy
We conducted a systematic literature search to identify
relevant publications in the MEDLINE [PubMed] and
CINAHL [EBSCO] databases in January 2014 (MND)
and updated it in December 2015 (RP).These databases
were chosen because we considered them as the most
relevant to the field of health services research. We
detail the search strategy in the Additional file 2: Table
S2 and Table S3. The search was not limited to a specific
time and study design, but it was limited to the German
and English languages. After the initial title and abstract
screening, publications were excluded if they were con-
sidered irrelevant to the topic or setting (RP, CGGS).
The remaining publications were divided to be read in
full-text and to be excluded according to predefined
criteria by one research team member (RP, SR, MND,
CGGS, BH, MH). Publications fulfilling the following
criteria were included for review: the research aim or
question focused on residents with dementia or CI in
German nursing homes and was answered based on
empirical data. Each decision to exclude a publication
was discussed and consented by the research team.
Data extraction and method of analysis
Two researchers (RP, SJ) read the included articles in
full-text and extracted the data: SJ conducted an initial
data extraction, and RP checked all of the information
for accuracy. In the first step of the data extraction, an
overview of the data on the study aim, design and sam-
ple size were compiled. In the second step, the publica-
tions were sorted according to sample determination
procedure. Publications from one study using the same
method to identify residents with dementia/CI were sum-
marized; this was the case with publications from large
projects with various research aims and questions. To
answer the research questions, the following information
was extracted: information on the method of sample
determination, the definition and criteria used for demen-
tia diagnostics, the screening instrument(s) used, and the
qualification and training of the professionals involved.
The extracted findings and key characteristics of each
method were summarized in an overview, and differing
approaches were compared.
Results
The literature search yielded 650 articles. Sixty-four arti-
cles were identified to answer our research questions.
The results of the literature search can be seen in the
flow chart in Fig. 1.
The characteristics of the included studies are presented
in Table 1.
Methods to identify the study population residents with
dementia
All 64 articles focused on the population of nursing
home residents with CI. In 60 articles, dementia was
specified as the etiology of CI. In these articles, the term
“dementia” was used consistently in the title, abstract,
key words and research questions. Four articles focused
their research question on residents with CI without any
specification of etiology, which means they did not
clearly define dementia residents as their study popula-
tion [37–40]. However, in these articles the terminology
Fig. 1 Flow chart of literature search
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Table 1 Characteristics of included studies
Publication Author Study aim Study design Sample size
NH P
Experimental studies
[54] Bär et al. 2006 Efficacy of an individual approach in the care of people with dementia
to stimulate positive emotions
CT N/A 46
[82] Berg et al. 2010 Efficacy of snoezelen, structured reminiscence therapy and 10-minute
activation on apathy in dementia
C-RCT N/A 360
[107] Dichter et al. 2015 Testing the effectiveness of Dementia Care Mapping on PwD and
caregivers, exploring implementation facilitators and barriers
CT 9 154
[76] Graessel et al. 2011 Efficacy of a non-pharmacological intervention on the cognition of
residents with dementia
RCT (Follow-up) 5 98
[108] Halek et al. 2013 Efficacy of dementia care mapping on the quality of life of residents
with dementia
CT 9 N/A
[70] Kuske et al. 2009 Effectiveness of a nursing home training staff for the interaction
between residents with dementia and their caregivers
C-RCT 6 298
[77] Luttenberger et al. 2012 Efficacy of a non-pharmacological intervention on dementia
symptoms and need of care in NH residents with dementia
RCT 5 139
[78] Luttenberger et al. 2012 Sustainability of a non-pharmacological intervention after 10 months RCT (Follow-up) 5 61
[48] Majic et al. 2013 Efficacy of animal-assisted therapy on agitation/aggression and
depression in nursing home residents with dementia
RCT 18 65
[80] Pickel et al. 2011 Efficacy of occupational group therapy in dementia CT N/A 56
[51] Rapp et al. 2013 Efficacy of a complex guideline-based intervention on agitation and
the use of psychotropic drugs
C-RCT 18 304
[47] Reuther et al. 2014 Effect evaluation of dementia-specific case conferences (study
protocol)
C-RCT 12 360
[109] Schäufele et al. 2013 Efficacy of an interdisciplinary guideline to enhance the mobility of
residents with dementia in nursing homes
CT 31 707
[110] Schäufele et al. 2015
[81] Treusch et al. 2015 Effect evaluation of an occupational and sports therapy intervention
for PwD in NH
C-RCT 18 117
Observational studies
[85]a Afram et al. 2014 Exploration of reasons and variations for institutionalization of people
with dementia in 8 European countries according to caregivers
Cross-sectional 3 786
[86]a Alvira et al. 2015 Description of the association between reactions of informal
caregivers of people with dementia and health outcomes from
8 European countries
Cross-sectional N/A 119
[61] Becker et al. 2005 Development and validation of an instrument to assess quality of life
in dementia
Cross-sectional 11 121
[87]a Beerens et al. 2014 Exploration of the variance of quality of life and quality of care for
people with dementia from 8 European countries
Cross-sectional N/A 119
[88] Beerens et al. 2015 Assessment of factors that contribute to the change of quality of life
of people with dementia recently admitted to an NH from 8 European
countries
Longitudinal N/A 791
[22] Brune-Cohrs et al. 2007 Quality of dementia diagnosis in nursing homes Cross-sectional 2 200
[89]a De Mauleon et al. 2014 Determination of factors associated with the antipsychotic
prescription for PwD in 8 European countries
Cross-sectional N/A 119
[83] Dettbarn-Reggentin 2005 Evaluation of milieu-therapeutic living units on residents with
dementia
Longitudinal 3 60
[53] Dichter et al. 2013 Validation of the QUALIDEM in nursing homes Cross-sectional 43 634
[111] Dichter et al. 2014 Testing of the inter- and intra-rater reliability of the QUALIDEM
instrument to measure quality of life in PwD
Cross-sectional 9 161
[44]a Foebel et al. 2014 Description of patterns of antipsychotic drug use in PwD in nursing
homes in 7 European countries and Israel
Cross-sectional 9 496
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Table 1 Characteristics of included studies (Continued)
[72] Geiger-Kabsich and
Weyerer 1993
Validity of the Alters-Konzentrations-Test Cross-sectional 2 71
[91] Gietzelt et al. 2014 Study protocol for an RCT testing the effectiveness of behavioral
treatment for mild Alzheimer’s patients
Longitudinal 1 40
[41] Graessel et al. 2009 Validation of the Erlangen Test of Activities of Daily Living (E-ADL) Cross-sectional 2 46
[45] Gräske et al. 2014 Examination of variability and associated factors of quality of life
ratings
Cross-sectional 5 133
[66] Jakob et al. 2002 Prevalence and incidence of dementia in nursing homes compared
to private households
Longitudinal N/A 192
[69] Köhler et al. 2007 Validation of the Dementia Screening Scale (DSS) Cross-sectional 20 589
[37] Kölzsch et al. 2012 Description of pain treatment in nursing home residents with CI Cross-sectional 40 560
[68] König et al. 2014 Comparison of the costs of care for community-dwelling PwD and
PwD living in nursing homes
Cross-sectional N/A 48
[62] Lueken et al. 2007 Development of a short version of the Apathy Evaluation Scale
specifically adapted for nursing home residents with dementia
Cross-sectional N/A 356
[79] Luttenberger et al. 2012 Revalidation of the E-ADL scale Cross-sectional 5 139
[49] Majic et al. 2010 Pharmacotherapy in residents with dementia Cross-sectional 18 304
[50] Majic et al. 2012 Correlation of agitation and depression in nursing home residents
with dementia
Cross-sectional 18 304
[46] Makai et al. 2014 Validation of the ICECAP-O measure for wellbeing in older PwD in NH
and exploration of response-associated factors
Cross-sectional 1 95
[58] Marquard and Schmieg 2009 Relationship between architectural characteristics of the nursing home
and the residents ability to perform way finding tasks
Cross-sectional N/A 450
[59]
[75] Meyer-König et al. 1984 Examination of nursing home residents with a chronic brain syndrome Cross-sectional N/A 163
[38] Osterbrink et al. 2012 Prevalence of pain in nursing home residents with various cognitive
functions
Cross-sectional 13 436
[57] Palm et al. 2013 Evaluation of the provision of dementia care and identification of
resident- and facility-related factors associated with quality of life and
behavior
Longitudinal N/A N/A
[52] Palm et al. 2015 Comparison of case conferences between dementia-specialized versus
traditional care units
Cross-sectional 51 888
[67] Riedel et al. 2013 Prevalence of Parkinson’s disease, associated dementia and depression
in Dresden
Cross-sectional 36 195
[24] Schäufele et al. 2013 Prevalence of dementia and provision of dementia care in nursing
homes
Cross-sectional 58 4481
[65] Schuler et al. 2007 Validation study of the “Pain Assessment in Advanced Dementia
Scale” (PAINAD-G) in nursing home residents
Cross-sectional 8 99
[39] Schumacher et al. 1997 Prevalence of depression and CI in nursing home residents Cross-sectional 3 380
[23] Seidl et al. 2007 Prevalence of non-cognitive symptoms and psychopharmacological
treatment in nursing home residents with dementia
Cross-sectional N/A 145
[64] Seidl et al. 2009 Comparison of neurological soft signs of residents with AD with
residents without cognitive impairments
Cross-sectional N/A 120
[63] Seidl et al. 2011 Description of autobiographical memory deficits in residents with
dementia
Cross-sectional N/A 239
[84] Theison et al. 2009 Association of agitation in the morning and depression Cross-sectional 3 110
[73] Weyerer et al. 1990 Validation of the Brief-Assessment-Interview Cross-sectional 1 32
[71] Weyerer et al. 1995 Prevalence of dementia and depression in nursing home residents
from Mannheim and Camden
Cross-sectional 12 542
[56] Weyerer et al. 2004 Comparison of residents from day-care centers and nursing homes Cross-sectional 47 1644
[42] Weyerer et al. 2005 Evaluation of special and traditional dementia care in nursing homes Cross-sectional 31 1644
[43] Weyerer et al. 2010 Evaluation of special and traditional dementia care in nursing homes Cross-sectional 31 1644
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was not consistent throughout the article: the term
dementia and CI were used interchangeably.
The articles focusing on residents with dementia used
different methods to determine their study sample. We
identified 4 methods that were clearly described.
Nursing home residents with dementia were identified
in one of the following ways:
1. A study diagnosis that was evaluated during the
study.
2. A recorded medical diagnosis.
3. A recorded medical diagnosis and an additional
cognitive screening performed during the study.
4. A cognitive or accordant screening.
1. Study diagnosis
In 17 articles, a study diagnosis of dementia was
used to determine the participant sample
(Table 2). The diagnosis was newly assessed either
in all residents or in residents with a diagnosis that
had previously been documented.
2. Recorded medical diagnosis
In 6 articles, the recorded diagnosis was the
criterion for determining the sample participants
(Table 3). In the study by Graessel et al. [41],
attending physicians confirmed the recorded
diagnosis; in the study by Weyerer et al. [42, 43],
the diagnosis was used as an indirect inclusion
criterion. In this study, the dementia diagnosis was
an admission criterion for the care unit that
participated in the study (Dementia Special Care
Unit). This study does not report whether the
diagnosis was confirmed. In 3 articles, the diagnosis
was obtained from the residents’ records [44–46];
1 article reported that the dementia type was
evaluated according to the ICD classification (as
recorded), and the dementia severity evaluation was
guideline-based and performed according to the
recommended MMSE cutoff values [46].
3. Recorded medical diagnosis and screening
In 20 articles, the recorded medical diagnosis of
dementia was used as a criterion to determine the
sample participants, but it was combined with the
results of a cognitive screening measure (Table 4).
In 19 studies, a resident was included if the result
of the MMSE also indicated CI; 1 study included a
resident if a diagnosis was recorded and the result
of a screening using the Functional Assessment
Staging Test (FAST) indicated dementia [47]. One
study used a stepwise approach [48–51]: in the
case of an incongruity between the diagnosis and
the MMSE result, additional diagnostics were
performed to decide whether a resident fulfilled
the inclusion criteria.
4. Screening
In 10 articles, residents with dementia were
identified by 1 screening or a combination of 2
screenings (Table 5). In these studies, an existing
diagnosis was recorded, but it was not used as the
inclusion criterion. Palm et al. [52] used the place
of residence in a Dementia Special Care Unit as an
inclusion criteria as well as the results of a
cognitive screening to define their sample. One
article reported exclusion criteria that were used
to differentiate dementia from other psychiatric
disorders [53].
The 3 studies (4 articles) that investigated
residents with CI exclusively used screenings to
identify their study participants (Table 6).
Seven publications could not be classified
according to the 4 groups explained above
Table 1 Characteristics of included studies (Continued)
[90] Wubker et al. 2015 Comparison of costs for PwD receiving home care versus nursing home
care in 8 European countries
Cross-sectional N/A 76
[40] Wulff et al. 2012 Description of perceived autonomy of nursing home residents with
and without CI
Cross-sectional 40 560
[93] Zenthofer et al. 2014 Comparison of oral hygiene and health status of nursing home
residents with and without dementia.
Cross-sectional N/A 93
Qualitative studies
[55] Bär et al. 2003 Identification of characteristic situations accompanied by positive
emotions
Qualitative N/A 29
[60] Becker et al. 2006 Identification and cross-validation of patterns of competence in
nursing home residents.
Qualitative N/A 362
[92] Nordheim et al. 2015 Evaluation of the use of tablet PCs in PwD in NH Qualitative 1 14
AD Alzheimer’s disease, C-RCT Cluster-randomized controlled trial, CT controlled trial, N/A not available, NHs nursing homes, P Participants, PwD People with
dementia, RCT Randomized controlled trial
aThe number of participants reported from this international study refers to the German sample only
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Table 2 Overview of studies that determine study participants with dementia based on a study diagnosis
Publications Method of sample determination Definition and diagnostic criteria used for (new)
dementia diagnosis
Screenings performed Qualification and training of professionals
performing screenings/diagnostics
[22] Diagnostics performed for every resident with an
existing dementia diagnosis
▪ Clinical examination
▪ Semi-standardized interview and neuropsychological
testing according to ICD-10 criteria
▪ Consolidation of existing diagnostic findings
▪ NINCDS-ADRDA criteria for diagnosis of AD
▪ Consensus criteria for frontotemporal dementia
▪ Petersen criteria for mild cognitive impairment (MCI)a
▪ NINDS-AIREN for vascular dementia
MMSE, CDR, Behave-AD, BPRS,
HDRS 17, B-ADL
Diagnosis: Physician with experience in
geriatric psychiatry
[23] Diagnostics performed by physicians from the
research team for every resident fulfilling one of
the criteria:
▪ Presence of dementia diagnosis in the nursing
records
▪ Resident appears forgetful
▪ Resident has problems with orientation within
the NH
▪ NINCDS-ADRDA criteria on the basis of clinical
examination, existing assessments of status and
progress, existing diagnostic findings (technical
investigations)
▪ Dementia was classified into different types: AD,
vascular dementia, mixed type, frontotemporal
dementia
MMSE, GDS, Clock Drawing Test,
CERAD entire battery, BAGI, AES,
NPI
Screening instruments and diagnosis:
Experienced geriatric psychiatrist with
formal training in the administration







[66] Diagnostics performed for a random sample of
nursing home residents
▪ SIDAM-interview for the assessment of cognitive
function; in case of severe physical impairment CDR
▪ Diagnosis of etiological subtype based on the findings
from the SIDAM-interview
▪ Diagnosis discussed in an expert conference of
physicians and psychologists according to DSM-III-R
SIDAM, MMSE or CDR Diagnosis: Physicians and psychologist
who received training in conducting
structured interviews
[67] Diagnostics performed for a random sample of
residents with Parkinson’s disease
▪ Diagnosis assessed according to DSM-IV-TR criteria




Screening instruments and diagnosis:
Study monitor with a medical education
[69] Diagnostics in the study was performed for all
nursing home residents.
▪ No definition or diagnostic criteria stated
▪ Diagnosis assessed using the CDR (≥ 1)
MMSE, BAS-DEM, CDR, DSS, BAI Diagnosis: Trained clinical psychologist
Screening (DSS): Licensed geriatric nurses
with frequent contact with the residents
during the previous 4 weeks
[70] Diagnostics in the study was performed for every
consenting resident.
▪ No definition or diagnostic criteria stated
▪ Diagnosis assessed using the CDR (≥ 1)
CDR, MMSE, Barthel-Index Diagnosis: Determined in multidisciplinary
consensus conferences held by
psychiatrists, clinical psychologists and
health and nursing specialists.
Screening instruments: Not specified
[71] Diagnostics performed for all NH residents ▪ No definition or diagnostic criteria stated
▪ Diagnosis assessed using the BAI (3-8 = mild to
severe dementia)
BAI Interviews performed by trained NH staff
with experience in clinical psychology
and psychiatry
[72] Diagnostics performed for NH residents able to
be interviewed
▪ Assessment of diagnosis according to Feighner-criteria
▪ Dementia severity cutoff value (MMSE≤ 23 minimum
mild dementia)













Table 2 Overview of studies that determine study participants with dementia based on a study diagnosis (Continued)
[73] Diagnostics in the study performed for a
non-defined sample of NH residents
▪ Diagnosis assessed according to the Feighner criteria
and compared with a diagnosis assessed with the BAI
(BAI 0-2 = most likely no dementia, 3-7 =mild to
moderate dementia, 8 = severe dementia)
BAI Diagnosis (Feighner criteria): experienced
NH manager
[75] Diagnostics for organic psycho syndrome (OPS)
(dementia) performed in a non-defined sample
of NH residents
▪ Differentiation of OPS severity based on an assessment
of cerebral dysfunction and changes in personality
Not specified Not specified
[68] Diagnostics in the study performed for all
included participants
▪ SIDAM interview was conducted
▪ Diagnosis was based on a consensus between study
interviewers and an experienced geriatrician or
geriatric psychiatrist according to DSM IV for Alzheimer
or ICD-10 or DSM III R criteria for multi-infarct
dementia and other etiology
▪ Diagnostic criteria: objective deficits in memory and
another cognitive domain, impairment in activities of
daily living
▪ Classification of dementia was based on the CDR
(≤ 1 =mild, 2 =moderate, 3 = severe)
▪ Assessed data were combined into simple and
weighted count scores
SIDAM, CDR, MMSE, Barthel-Index
for ADL impairment, IADL
impairment scale, 28 chronic
conditions
Trained physicians or psychologists
conducted interviews with participants
and their caregivers.
AD Alzheimer’s disease, ADL Activites of daily living, AES Apathy Evaluation Scale, AKT Alters-Konzentrationstest, B-ADL, Bayer-Activities of Daily Living Scale, BAGI Bielefelder Autobiografisches Gedächtnisinventar,
BAI Brief Assessment Interview, BAS-Dem Brief Assessment Schedule, Behave-AD Behavioral Pathology in Alzheimer’s Disease, BPRS Brief Psychiatric Rating Scale, CDR Clinical Dementia Rating, CERAD The Consortium to Establish
a Registry for Alzheimer’s Disease, DSS Dementia Screening Scale, DSM Diagnostic Statistical Manual, E-ADL Erlangen Test for Activities of Daily Living, GDS Global Deterioration Scale, HDRS 17 Hamilton Depression Scale 17,
IADL Instrumental Activities of daily living, MMSE Mini Mental State Examination, NOSGER Nurses’ Observation Scale, NPI Neuropsychiatric Inventory, PANDA Parkinson Neuropsychometric Dementia Assessment, SIDAM Structured
Interview for the Diagnosis of Alzheimer’s Dementia, Multi-infarct dementia and dementias of other etiology












Table 3 Overview of studies that defined study participants with dementia based on a recorded diagnosis
Publications Method of sample determination Definition and diagnostic criteria used for (new) dementia
diagnosis
Screenings performed Qualification and training of professionals
performing screenings/diagnostics
[41] A suspected dementia diagnosis (by nursing staff)
or existing dementia diagnosis confirmed by the
attending GP
▪ ICD-10 criteria
▪ Dementia severity stages: MMSE: 0-9 severe, 10-17 moderate,




[42] Diagnostics not performed in the study, but the
admission criteria for the living unit were used as
inclusion criteria (dementia diagnosis, minimum
of care level 2, behavioral problems according to
the CMAI, and mobility)
▪ No information given on the diagnostic procedure of the
existing diagnosis
DSS Professional nursing staff, training of raters
is not specified
[43]
[44] Dementia diagnosis was derived from the interRAI
LTCF assessment in the records
▪ No information given on the diagnostic procedure of the
existing diagnosis
InterRAI (LTCF) Not specified
[45] Residents with a medical diagnosis of dementia
were included.
▪ No information given on the diagnostic procedure of the
existing diagnosis
GDS Measures were assessed by nurses.
[46] Residents with a medical diagnosis of dementia
were included.
▪ Assessment of the dementia type according to the ICD-10
classification (as recorded)
▪ Assessment of dementia severity according to the German
guideline for dementia and recommended MMSE cutoff
values (0-9 severe, 10-19 moderate, 20-26 mild)
MMSE Not specified.
DSS Dementia Screening Scale, E-ADL Erlangen Activities of Daily Living, GDS Global Deterioration Scale, interRAI LTCF international Resident Assessment Instrument Long Term Care Facility, MMSE Mini Mental State












Table 4 Overview of studies that defined study participants with dementia based on a recorded diagnosis and additional cognitive screenings
Publications Method of sample determination Definition and criteria used for (existing) dementia
diagnostics
Screenings performed to define
and describe dementia
Qualification and training of professionals
involved
[48] Residents with dementia were identified using
a mixed stepwise approach:
1st step: Multiple combined inclusion criteria:
▪ Presence of dementia diagnosis in the nursing
and medical records and
▪ MMSE ≤ 24
2nd step: In case of incongruity of diagnosis and
MMSE result, dementia diagnostics were
performed, diagnostics were also performed
for residents with a suspected dementia but no
diagnosis
▪ Exclusion criteria: Presence of other neurological/
psychiatric diseases that could explain patients’
decline in cognitive function (schizophrenia,
bipolar disorders, mental retardation)
▪ Existing dementia diagnosis performed in 70 %
by GPs and 30 % by medical specialists and
according to ICD-10 criteria
▪ An ICD-10/DSM-IV conform study diagnosis was
assessed based on clinical investigation and MMSE
▪ Dementia severity stages: MMSE: 0-9 severe/very
severe; 10-18 moderate; 19-24 = mild dementia
MMSE, FAST, AES, NPI Diagnosis: Physician from the research team
who was experienced in geriatric psychiatry
Screening instruments: Specifically trained
raters, including medical students with an
advanced academic degree and physicians





[76] Residents with dementia were identified using
two combined inclusion criteria:
▪ Confirmed presence of primary degenerative
dementia and
▪ MMSE < 24
▪ Exclusion criteria: presence of other neurological/
psychiatric diseases that could explain patients’
decline in cognitive function (such as addiction,
major depression, or schizophrenia), high nursing
care needs, blindness, deafness
▪ Dementia diagnosis confirmed according to
ICD-10 (F00, F03, or G30), exclusion of vascular
(F01) and secondary (F02) dementia
▪ Dementia severity stages: MMSE: 0-9 severe;




Diagnosis: confirmed by the attending
physician
Screening instruments: Psychology students




[80] Residents with dementia were identified using
two combined inclusion criteria:
▪ Presence of a dementia diagnosis; and
▪ MMSE < 24, GDS stadium 4, 5 or 6
▪ Exclusion criteria: presence of other neurological/
psychiatric diseases that could explain patients’
decline in cognitive function (such as addiction,
major depression, or schizophrenia)
Dementia diagnosis according to ICD-10 in the
doctoral records




[82] Residents with dementia were identified using
2 combined inclusion criteria:
▪ Existing diagnosis of dementia and
▪ MMSE ≤ 24
▪ Exclusion criteria: Korsakoff’s syndrome or CI
caused by diseases other than dementia
No specified information given on the diagnostic
procedure of the existing diagnosis
MMSE, CDR, AES Not specified
[83] Residents with dementia were identified using
2 combined inclusion criteria:
▪ Admission criteria to the living unit were used
as inclusion criteria (presence of a dementia
diagnosis) and
▪ MMSE < 18
No specified information given on the diagnostic
procedure of the existing diagnosis












Table 4 Overview of studies that defined study participants with dementia based on a recorded diagnosis and additional cognitive screenings (Continued)
[84] Residents with dementia were identified using
two combined criteria:
▪ Presence of a dementia diagnosis; and
▪ MMSE ≤ 27 and DemTect (scores of 6-8) for
residents with a MMSE score between 24-27
▪ No specified information given on the diagnostic
procedure of the existing diagnosis
▪ Dementia severity stages: MMSE: ≤ 10 severely
demented; 11-19 moderately demented,
20-27 mild dementia
MMSE, DemTect Not specified
[85] Residents with dementia were identified using
2 combined criteria:
▪ S-MMSE-Score ≤ 24
▪ Exclusion criteria: primary psychiatric diagnosis
or Korsakov’s syndrome
▪ No specified information given on the diagnostic
procedure of the existing diagnosis
▪ Different dementia severity stages were used
MMSE, NPI, Katz-Index Formal diagnosis of dementia as determined
by a healthcare professional (physician,









Residents with dementia were identified using
2 combined criteria.
▪ Medical diagnosis of dementia
▪ FAST > 1
▪ No specified information given on the diagnostic
procedure of the existing Diagnosis
FAST, NPI, PSMS ▪ Data were assessed by trained study
assistants who interview two caregivers
simultaneously
▪ Study assistants (mainly students) undergo
a 2-day training on the use of the
questionnaires and receive a manual
▪ The first data collection was assisted by
senior and junior researchers
AD Alzheimer’s disease, ADAS Alzheimer’s disease Assessment Scale, AES Apathy Evaluation Scale, CDR Clinical Dementia Rating, E-ADL Erlangen Test for Activities of Daily Living, FAST Functional Assessment Staging,
GDS Global Deterioration Scale, MMSE Mini Mental State Examination, NOSGER Nurses’ Observation Scale, NPI Neuropsychiatric Inventory
aThe reporting of instruments is not consistent across the publications. Therefore, all instruments used were summarized in this group. The studies also differ also regarding the criteria used to diagnose. Majic 2012
referred to DSM- IV, other publications to ICD-10













Table 5 Overview of studies that defined study participants with dementia based on cognitive screenings
Publications Method of sample determination Information about dementia diagnosis Screenings performed to define
and describe dementia





Residents with dementia were identified using one
criteria
▪ FAST≥ 2
▪ Exclusion criteria: documented diagnosis of
schizophrenia or other psychotic disorders
Existing diagnosis of dementia recorded
but not used as an inclusion criteria
MMSEa, FAST, NPI, PSMS Screening instruments: Caregivers who were familiar
with the resident were interviewed from a trained
external research assistant (registered nurses and
students in health care study programs)
[52] Residents were included using 2 criteria:
▪ Place of residence is a Dementia Special Care Unit
▪ Cognitive impairment according to DSS > 2
Existing diagnosis of dementia recorded
but not used as an inclusion criteria
DSS, NPI, PSMS Screening instruments were completed by nurses
familiar with the resident; questionnaires were
accompanied by a manual to support assessment
[109]b
[110]
Residents with dementia were identified using
2 combined criteria
▪ Dementia according to DSS; and
▪ Mobile according to Rivermead Mobility Index
Existing diagnosis of dementia recorded
but not used as an inclusion criteria; no
information is given on existing diagnosis
DSS, NPI, Barthel-Index Screening instrument: registered nurses who are
familiar with the resident (primary nurse)
[91] Residents with dementia were identified based on
the MMSE screening < 24
No information given on existing
diagnosis
MMSE, Barthel-Index Not specified
[92] Residents with dementia were identified based on
the MMSE screening < 24
▪ Dementia severity stages: MMSE ≤ 10 severe,
11-17 moderate, ≥ 18 mild
No information given on existing
diagnosis
MMSE, Barthel-Index Not specified
[93] Residents with dementia were identified based on
the MMSE screening
▪ MMSE cutoff≤ 20
No information given on existing
diagnosis
MMSE MMSE was performed by three psychologists.
DSS Dementia Screening Scale, FAST Functional Assessment Staging, MMSE Mini Mental State Examination, NOSGER Nurses’ Observation Scale, NPI Neuropsychiatric Inventory, PANDA Parkinson Neuropsychometric
Dementia Assessment, PSMS Physical Self Maintenance Scale
aMMSE values are assessed only in a subsample in the study from Dichter et al. (2013) and recalculated into FAST values












(Table 7). In 4 of these publications, all of the
residents from a participating nursing home or
living unit were included in the study and
investigated with respect to various indicators for
dementia (dementia diagnosis in the records and
results of cognitive screenings) [24, 54–56]. In
these studies, the sample was described, but
participants were not selected or assigned based
on these indicators. One article is a study
protocol; the method to define residents with
dementia was not determined, only the
measurements that were intended to assess
dementia [57]. In 2 publications [58, 59], the
method to identify residents with dementia was
not reported at all.
Reporting about dementia diagnostics within the study
Fifteen articles reporting on studies with a newly assessed
diagnosis detailed diagnostic criteria and gave information
on the diagnostic process or referred to related articles that
described the diagnostic process [22, 23, 48–51, 60–68]. As
shown in Table 2, these studies referred to the definition
and diagnostic criteria for Alzheimer’s disease and vascular
dementia from the ICD, DSM, or NINCDS. Studies that
referred to the diagnostic criteria for dementia subtypes
reported a more comprehensive diagnostic procedure
Table 6 Overview of studies that investigated study participants with cognitive impairment
Publications Method of sample determination Screenings performed to
define and describe CI
Qualification and training of professionals involved
[37] Assessment of CI performed for a random sample
of NH residents.
MMSE, Barthel-Index Data were collected through face-to-face interviews
by trained research personnel
[40] ▪ MMSE: 0-17 = severe CI; 18-23 = moderate CI;
24-30 = no or mild CI
[38] Assessment of CI was performed for NH residents
> 65 years without verbal impairments.
MMSE Trained study assistants (licensed nurses or students
in health care programs) who received a comprehensive
training in using the MMSE
▪ MMSE: 0-9 severe CI; 10-17 moderate CI;
18-30 = no/mild CI
[39] Assessment of CI was performed for all residents
of the participating NHs.
MMSE, GDS Not specified
▪ MMSE: < 15 severe CI, 16-20 relevant CI
▪ GDS: 2-3 mild CI, 4-5 moderate CI, 6-7 severe CI
CI cognitive impairment, GDS Global Deterioration Scale, MMSE Mini Mental State Examination
Table 7 Overview of studies that did not clearly define participants with dementia




Screenings performed to define
and describe dementia
Qualification and training of professionals
involved
[24] Every resident on the living
unit enclosed in the study
and described with respect
to dementia-related
characteristics
Medical diagnosis is derived
from the medical records
and coded according to
ICD-10.
Presence of dementia diagnosis in
the nursing records, DSS (rating
according to CDR: mild (CDR 1),
severe (CDR 2), very severe (CDR 3)
Screening instruments: Nurses who are
familiar with the resident performed
the ratings; oral and written instructions
were provided by the research team
[54] Every resident on the living
unit included in the study
and described with respect
to dementia-related
characteristics
Not specified GDS (> 1 beginning dementia, > 3
moderate dementia, > 5 severe
dementia), MMSE, CERAD Verbal




[56] Every resident on the living
unit is enclosed in the study
and described with respect
to dementia-related
characteristics
No information is given on
the diagnostic procedures
of the existing diagnosis.
Presence of dementia diagnosis in
the nursing records, DSS
Screening instruments: Professional




Every resident on the living
unit included in the study
and described with respect
to dementia-related
characteristics
Medical diagnosis is derived
from the nursing records.
Presence of dementia diagnosis in
the nursing records, DSS, FAST,
MMSE as recorded in the nursing
records
Screening instruments: Nurses who are
familiar with the residents and received
training or supervision by a trained
study coordinator (NH staff)
[58] Procedure to identify
residents with dementia not
reported
Not specified Not specified Not specified
[59]
CDR Clinical Dementia Rating, CERAD The Consortium to establish a Registry for Alzheimer Disease’s, DSS Dementia Screening Scale, FAST Functional Assessment
Staging, GDS Global Deterioration Scale, MMSE Mini Mental State Examination
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[22, 60–68] than those reported in studies that did not
refer to dementia subtypes. These diagnostic proce-
dures were composed of clinical examinations, interviews,
neuropsychological testing and a review of existing diag-
nostic findings from technical investigations. The articles
examined did not specify the number or types of findings
available from technical investigations or how missing
findings were accommodated.
Three studies did not refer to any definition or diag-
nostic criteria of dementia, but solely reported the
instrument on which the diagnosis was based [69–71].
Two studies conducted prior to 2000 [72, 73], assessed a
diagnosis on the basis of the Feighner criteria [74]. Nei-
ther of those studies provided any detailed information
about the diagnostic process or about which instruments
were used to assess the criteria. One pre-1990 study did
not report the definition, the diagnostic criteria, or any
instrument that was used [75].
The majority of studies in which the diagnosis was newly
assessed within the study indicated that a battery of neuro-
psychological tests was used [22, 23, 48–51, 60–70, 72].
Two of these studies indicated that the final diagnosis was
based on the Clinical Dementia Rating (CDR) [69, 70]; in
another study, this instrument was used for staging [68].
The compilation of psychological tests differed in the
studies with regard to the assessment of cognition, be-
havior and function. For assessing cognition, the MMSE
was the only instrument that was used in all of these
studies. Studies using a battery of neuropsychological
tests included different tests for cognitive function: the
MMSE was combined with the Global Deterioration
Scale (GDS), the CDR, the Clock Drawing Test, the Brief
Assessment Schedule (BAS-Dem) and the Parkinson Neu-
ropsychometric Dementia Assessment (PANDA). With
exception of the PANDA (used for a subsample of resi-
dents with Parkinson’s disease) [67] and the CDR (used in
cases of severe physical impairment) [66], the studies did
not specify whether all of the instruments were adminis-
tered to each resident or whether any particular instru-
ment was used for residents with certain characteristics.
For assessing behavior and function, the researchers
also used different instruments, which can be viewed
in Tables 2, 3, 4, 5 and 6.
The scope and the rationale of each instrument’s
use in the diagnostic process were not clearly docu-
mented in most studies. In 10 studies, it was not
clear which instruments were essential to the decision
about the diagnosis because no cutoff values were re-
ported [22, 23, 60–67]. Moreover, it was not clearly
stated which instruments were used for diagnostics
and which were used for study purposes only (including
the description of the study sample), as an outcome meas-
ure, or for validity testing. Five studies reported cutoff
values [69–73]; 2 of these studies used the CDR with a
cutoff ≥ 1 to assess the dementia diagnosis [69, 70]; 3 stud-
ies reported cutoff values for the MMSE and the BAI to
stage dementia severity [71–73].
The assessment process for the diagnosis was described
briefly in 5 articles: 3 articles reported that the administra-
tion of instruments was carried out with the help of inter-
viewers [22, 66, 67], whereas 3 studies reported that the
diagnosis was agreed to in a multidisciplinary conference
[66, 68, 70]. In all of the studies that assessed a new diag-
nosis of dementia medical staff with geriatric experience,
primarily physicians, performed the diagnostics.
Reporting about dementia diagnostics prior to the study
Altogether, in 26 articles, the recorded diagnosis was used
as an inclusion criterion with or without additional screen-
ings (Tables 3 and 4). Twelve articles reported that existing
diagnoses used to determine the sample were performed or
confirmed according to ICD [41, 46, 48–51, 76–81]. None
of these articles gave more explicit information about the
pre-study diagnostic procedure or about whether an exist-
ing diagnosis was confirmed by the attending physician. In
14 articles, neither the definition of dementia and/or its
diagnostic criteria were reported; in addition, no informa-
tion was provided about the diagnostic procedure that had
been undertaken prior to the study [42–45, 47, 82–90].
In 17 articles, it was reported that in addition to the
recorded diagnosis or performed screenings, exclusion
criteria were also used in the study [48–51, 53, 76–80,
82, 85–90]. These comprised other neurological or psy-
chiatric diseases that could cause CI.
Reporting about screening of cognitive impairment
CI was measured in all studies, but with different instru-
ments and cutoff values.
The use of the MMSE was reported in 47 articles and
represents the instrument most often used to identify
residents with dementia and the stage of its severity. A
broad range of cutoff scores for dementia severity was
reported for the MMSE. Seven studies referred to an
MMSE of < 25 [37, 40, 48–51], 6 studies used a cutoff
of ≤ 24 [85–90], 8 articles referred to a cutoff of < 24 to
detect mild dementia [76–80, 82, 91, 92], and 4 articles
referred to a more conservative cutoff. [39, 41, 83, 93]
One article specified a higher cutoff value of ≤ 27 but
conducted confirmatory testing with the Geriatric Depres-
sion Scale (GDS) for residents with an MMSE between 24
and 27 [84]. One article use a cutoff value of < 27 without
additional testing [46]. The studies also used different cut-
off values for staging dementia (Table 8).
Thirteen articles did not report a cutoff value for the
MMSE but instead reported mean scores for the study
sample [22, 23, 60–70].
For the CDR, a consistent cutoff value was reported
(≥ 1) in 3 studies [68–70]; 3 articles did not report any
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cutoff values for the CDR [22, 66, 82]. For the GDS,
consistent cutoff values were most often reported.
Schumacher et al. and Bär et al. [39, 54, 55] speci-
fied mild CI as corresponding to a GDS of 2-3,
moderate CI as corresponding to a GDS of 4-5, and
severe CI as corresponding to a GDS of 6-7. Pickel
et al. [80]. set a cutoff value of > 3 for mild, moder-
ate or severe dementia.
In addition to differences concerning the use of instru-
ments, we also identified differences regarding the pro-
fessionals who administered the instruments to assess
CI. Studies using the assessments to state a dementia
diagnosis primarily used physicians. Studies assessing CI
without making a statement on the dementia diagnosis
used physicians, psychologists, nurses, medical students
and students from other health care programs (see
Tables 2, 3, 4, 5 and 6). Some studies stated that the as-
sessors were experienced in the field and when nurses
were assessors, it was stated that they were familiar
with the residents. Training for raters who performed
the cognitive assessments was conducted in numerous
studies (see Tables 2, 3, 4, 5 and 6); however, the dur-
ation of training, training concepts and training evalu-
ation were not specified.
Discussion
This review reveals a sampling challenge for dementia
studies in German nursing homes in health services re-
search: uncertainty related to existing dementia diagnoses,
constrained resources and ethical dilemmas concerning
accurate diagnostic procedures and the achievement of
study validity. When designing a sampling plan, the ad-
vantages of convenient and efficient access and ethical
considerations related to the residents must be weighed
against participant-related validity concerns.
In our review, we found 4 sampling methods to identify
residents with dementia:
1. A study diagnosis;
2. A recorded medical diagnosis;
3. A recorded medical diagnosis and additional
cognitive screening; or
4. Cognitive or accordant screening.
Each method has to be discussed with regard to its
practicability and validity.
A guideline- and criteria-based diagnosis of dementia
is the most valid criterion to select study participants
when the aim of the study is to target people with de-
mentia. The clear benefits of this method are a thorough
assessment of dementia-related conditions and a sound
differential diagnosis to ensure that the CI is not caused
by conditions other than dementia. Challenges related to
this approach are the resources required in terms of
time, costs and availability of physicians.
The performance of diagnostics by a member of the
research team enhances study validity by ensuring con-
formity to the criteria. As demonstrated in several stud-
ies [22, 23, 48–51, 60–68], criteria conformity can be
achieved in the evaluation of a dementia syndrome. In
these studies, both subjective and objective information
on the patient’s cognitive decline were thoroughly assessed.
However, the validity of the dementia subtype diagnosis, as
performed in a few of these studies [22, 23, 60–65], was
questionable. In particular, during the late stage of demen-
tia, a differentiation between dementia subtypes is difficult
and requires the use of disease progression measures such
as repetitive cognitive tests. It can be assumed that this
information was not readily available for a large number of
residents because the implementation of diagnostic mea-
sures, other than the collection of subjective information, is
infrequent in the German primary care sector. A survey of
23 German primary care physicians regarding the use of
diagnostic measures showed that only 3 physicians used
neuropsychological tests as a component of their diagnosis
[34]. There is also evidence showing that in primary care,
imaging techniques and other diagnostic features are sel-
dom used; misclassifications that lead to an overestimation
of vascular dementia were frequently discovered in several
studies [34, 94, 95].
With respect to the reporting of the diagnostic per-
formance, the studies lacked detailed information. Sev-
eral studies did not report which instrument was used to
assess which criterion, whether normative data were
used to determine CI, which cutoffs were used and how
missing data were addressed. It is recommended that
this information be provided when a dementia diagnosis
in the oldest-old population is evaluated [20]. Addition-
ally, information on training for the raters who con-
ducted the cognitive assessments was missing in all of
the studies. In our opinion, this is a crucial issue because
1 study showed that even physicians who underwent
Table 8 MMSE cutoff values for dementia staginga
Publication Severe Moderate Mild
[38, 41] 0-9 10-17 18-30b
[76–79] 0-9 10-17 18-23
[48–51] 0-9 10-18 19-24
[84] 0-10 11-19 20-27
[37, 40] 0-17 18-23 24-30b
[89] 0-9 10-21 > 21c
[46] 0-9 10-19 20-26
[92] 0-10 11-17 > 17
[90] 0-9 10-20 > 20c
aThis table only lists publications on studies that used the MMSE for a staging
of dementia/CI
bRange of values also cover people with no CI/dementia
cParticipants with a MMSE > 24 were excluded
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training in cognitive assessments may still fail to use
these diagnostic instruments correctly [34].
However, evaluating a study diagnosis also lacks feasi-
bility when resources are constrained. Imaging diagnos-
tics are critical because nursing home residents are often
too frail to transport, and nursing homes are often not
affiliated with a clinic. Consequently, appropriate tech-
nical devices may not be available. As we can see in the
studies that evaluated dementia subtypes, only existing
findings were used to conduct a subtype diagnosis. Thus,
the diagnosis must be made based on neuropsychological
and functional tests, clinical examinations and interviews
that are conducted by either geriatric psychiatrists or clin-
ical psychologists; this process requires time, experienced
assessors and willing participants. The study with the
largest sample size involved 589 residents from twenty
nursing homes in a German city [69]. Thus, performing
dementia diagnostics within a study seems feasible for a
sample size up to 600 people who live in a single city.
However, we assume that the evaluation of a dementia
diagnosis may have a negative impact on the willingness
to participate in a study if the assessment is overly bur-
dening or involves invasive procedures [96]. For example,
in 1 study, 20 of 113 eligible residents were unwilling to
submit to an MMSE [93]. For the majority of the nurs-
ing home population, legal guardians decide whether
the resident will participate. In our experience from
studies in the field, legal guardians are hesitant to per-
mit participation because studies involve measures that
will burden the resident.
The use of a recorded medical diagnosis as an inclusion
criteria may be appealing, especially in studies with large
samples and with a geographically widely dispersed popula-
tion. However, the well-documented inaccuracy of recorded
dementia diagnoses indicates that in a research situation,
this approach must be questioned [6, 30]. If researchers
cannot be sure which criteria have been used and how they
were measured, we must assume that the diagnosis may
not correspond to the established ICD- or DSM-criteria.
Consequently, misclassification threatens the internal valid-
ity of study results. In experimental trials, diagnostic dis-
crepancies may lead to heterogeneity in the intervention
and control group that may have an impact on treatment
effects. The inclusion of false-positive participants may
explain the failure to show treatment effects, and the exclu-
sion of false-negative participants both prolongs the recruit-
ment process and may cause a selection bias.
The third sampling method that combines a recorded
diagnosis with a cognitive screening is more feasible
than evaluating a diagnosis following defined criteria
and recommended procedures. Cognitive tests are com-
paratively easy and quick to administer and therefore,
their administration can be delegated to nursing-home
staff members who are more easily accessible than
geriatricians or psychologists, such as nurses or medical
students. This method may ensure a more homogenous
sample with respect to cognition, but it misses other
information about functioning and decline in function-
ality and cognition. Without this information, it is im-
possible to verify the diagnosis according to established
diagnostic criteria [30, 97]. The risk of including false-
positives can be reduced, but not eliminated. In this
respect, exclusion criteria are relevant. Several studies
reported that residents were excluded when diseases
other than dementia explained their cognitive decline.
However, the combination of a recorded diagnosis, a
cognitive screening and exclusion criteria still does not
reduce potential selection bias resulting from systemat-
ically missing false negatives. Furthermore, it is necessary
to decide what to do when combined inclusion criteria
contradict each other. In 1 study, these concerns were ad-
dressed. Majic and colleagues report that participants
were included with a recorded diagnosis of dementia, an
MMSE ≤ 24 and a duration of CI of > 6 months, but
diagnostics were performed in case of incongruity [48].
They report elsewhere that additional diagnostics were
performed in residents if the nursing home staff suspected
dementia, but there was no recorded diagnosis [49]. Other
studies did not sufficiently report how they addressed in-
congruity in the combined inclusion criteria and whether
they performed any measures to rule out the outlined
problems.
The fourth method that was identified in this review is
the use of a single test result. The instruments FAST,
DSS and the MMSE were used for this purpose.
The FAST staging procedure is used as a diagnostic
measure for dementia and relies on the assessment of
functional impairments that are attributable to dementia
[98]. This instrument was tested in its original language
on a sample that was composed of 16 participants who
had different levels of cognitive impairment and numerous
possible underlying diseases. The testing was conducted by
physicians who were in their postdoctoral training phase;
their results revealed excellent values for inter- and intra-
rater reliability and concurrent validity [99]. Unfortunately,
data on internal consistency and discriminant validity are
absent [100] as well as the results from the German version
of the FAST. To our knowledge, this instrument has not
been evaluated for its sensitivity or specificity when being
used to detect dementia. In the reviewed studies, it was
administered by health personnel, not physicians. Addition-
ally, there are no studies that compare the accuracy of this
instrument depending on if the instrument is administered
by physicians versus other health personnel.
The DSS is a 7-item scale that assesses both memory
and orientation at the time of assessment [69]. The instru-
ment was originally developed in the German language,
tested in 589 nursing home residents, and administered
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by nurses [69]. It was validated against the MMSE, BAS-
DEM and the CDR. Utilizing the CDR as the gold stand-
ard, the DSS was able to correctly classify more than 80 %
of residents; however, it showed small inaccuracies when
compared to the MMSE and BAS-DEM. Because the scale
is fast and easy to administer, this approach can be consid-
ered to be feasible in health services research, even though
its validity must be critically discussed. The scientific lit-
erature concordantly states that the assessment of single
domains of cognition, especially a single cognitive test,
cannot accurately diagnose dementia and should not be
used to substitute systematic evaluations, examinations
and laboratory tests [101]. Because the DSS does not
assess changes in cognitive functions, it is not possible to
determine if the present cognitive deficits had declined
over the past 6 months. Hence, the DSS will misclassify
residents who have acute cognitive deficits that are due to
infection or dehydration. The same misclassification can
occur in residents who have chronic cognitive impair-
ments due to other diseases.
In our review, the MMSE was the instrument that was
most often chosen to define the inclusion criteria. The
rationale for using the MMSE in the studies was primar-
ily its degree of popularity and widespread utilization. A
meta-analysis on the accuracy of the MMSE confirms
this choice: in high prevalence settings, the MMSE shows
a sensitivity and specificity of 77 and 90 %, respectively
[15]. The notable shortcomings of the MMSE in the
context of nursing home research were rarely discussed in
the studies, although those shortcomings threatened the
internal validity of the study results. The MMSE shows a
floor effect in very severe score ranges, people with little
formal education, and people with severe language prob-
lems. [101] Several items are strongly influenced by age and
education, which implies a need to adjust MMSE scores
when establishing thresholds. We found a variety of MMSE
thresholds for staging dementia in the reviewed studies - a
result that was also reported in other reviews [12, 20]. This
result may be a consequence of missing normative data for
the age group of the oldest-old and standardized age-
adjusted cutoff values. The authors of a meta-analysis on
dementia screening and case-finding tool validation studies
suggest alternatives to the MMSE such as the Mini-Cog
[102]. However, the suitability of these screening tools for
nursing home research needs to be investigated.
In this respect, an associated question must be discussed
in health services research in nursing homes: is a valid
diagnosis of dementia necessary to define the study popu-
lation? If the aim of the study is to prove the benefit of
an intervention that should be provided exclusively to
residents with dementia, a valid diagnosis is essential to
prove the benefit for this population. If the aim of the
study is to prove a benefit for residents with cognitive and
functional impairments independent of their etiology, a
dementia diagnosis is dispensable. The same question
must be considered by clinicians because in the absence of
disease-modifying treatments, the primary advantage of a
diagnosis for the oldest-old population has to be deter-
mined to justify resource-intensive diagnostics [20]. The
need to perform diagnostics in the nursing home popula-
tion must also be ethically justified because psychological
tests can be significantly burdensome to people with CIs.
We also found 4 articles that aimed to investigate resi-
dents who had CI but did not explicitly have dementia.
To us, it was unclear why some studies focused on the
population of people with CI but not on people with
dementia because the authors did not elaborate on the
question whether the etiology of CI played a role with
respect to their research focus. In 2 publications, the
terms “dementia” and “CI” were used interchangeably
[39, 40]. If the authors did not explain why they defined
their population based on a disease or a symptom and
later failed to distinguish between the 2 conditions, one
may ask whether the question was sufficiently addressed.
In addition to the variability of case ascertainment
strategies in dementia studies, this review mirrors the
developments in knowledge, concepts, differentiations
and diagnostic criteria related to “dementia” that have
occurred during the last 30 years. With each decade of
dementia studies in German nursing home research, the
diagnostic procedures were refined and reflect methodo-
logical innovations. Therefore, the definition and assess-
ment of dementia and CI must be considered against the
respective state of knowledge at the time a particular
study was conducted. For example, in 1 study from 1993
[72], the Feighner criteria were applied; these criteria
had been introduced in the DSM-III and became available
in the German language with the German translation of
the DSM-III in 1984. On the contrary, another study [75]
was published the same year; it is obvious that those
researchers could not apply today’s diagnostic criteria
because they were not available at the time the study was
designed and conducted.
An overview of the advantages and disadvantages of
the different case ascertainment strategies is summarized
in Table 9.
Strengths and limitations
The problem of inconsistent management of methodo-
logical challenges in dementia research has already been
recognized and has led to an initiative on how to improve
the reporting of these challenges in clinical studies [103].
However, studies of the outlined problem of inconsistent
case ascertainment strategies in nursing home research
have been lacking to date. We consider this as a prerequis-
ite for improving dementia research in the nursing home
sector and outline this as the major strength of this study.
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The generalizability of the displayed results is con-
strained to one country (Germany). However, we assume
that the outlined problem can also be demonstrated in
other countries, but this must be proven in a later review.
Perhaps in countries in which physicians are employed in
nursing homes and adherence to diagnostic standards can
be guaranteed, the reliance on a recorded diagnosis can be
received less critically.
As discussed, the reporting of diagnostic procedures
was partially insufficient; in particular, different publica-
tions from a single study provided varied information
about their case ascertainment. In some studies, it was not
clear whether the assessments were used exclusively for
study purposes, for diagnosis, or both. In particular, the
scope of assessments with respect to behavior and func-
tion was not described clearly, making it unclear whether
these instruments were also used for diagnostic proce-
dures. In an effort to rule out this lack of clarity, we un-
successfully attempted to contact the authors. The short
reporting made it also impossible to assess the quality of
diagnostic procedures or the associated risk of bias.
Because of the descriptive objective of the review, it
has not been registered in a review register.
Conclusions
Considering the findings of our review, we suggest the
following principles to improve the validity and compar-
ability of study results on dementia in nursing homes.
Investigators must clearly distinguish whether their
research addresses residents with CIs or residents with
dementia with an appropriate etiology. If residents with
dementia are addressed, it should be in accordance with
the study aim. Studies that address the population of
nursing home residents with dementia should report in
detail which method of case ascertainment was used
and should discuss the limitations associated with each
method. In our opinion, a criterion-based diagnosis is
essential when a study addresses explicitly residents with
dementia. If residents are included in studies based on
diagnoses that do not conform to established criteria, the
results from different studies are not comparable. To
ensure that a diagnosis conforms to criteria, clinicians
who are members of the research team should evaluate a
diagnosis during the research project. When financial or
human capacities are constrained, one should consider
alternative methods to a face-to-face consultation by a
geriatric physician, psychologist or psychiatrist. Several
methods utilizing an expert panel are described for the
diagnosis of dementia [104]. The method by Magaziner et
al. [30] appears promising for research purposes: 2 clini-
cians decide whether dementia is present based on the
resident’s history and neuropsychological tests performed
by lay evaluators. Compared to direct clinical evaluation,
agreement was satisfactory (76 %). Another promising ap-
proach is a nurse-administered diagnosis. Studies showed
a high agreement between a nurse-administered diagnosis
and a multidisciplinary team diagnosis in determining
mild CI in primary care [105]; in addition, there is agree-
ment between a Memory Clinic diagnosis [106] and a
moderate agreement with the ICD-10 diagnosis (ibd.). To
our knowledge, a nurse-administered diagnostic procedure
for dementia in nursing home residents has not yet been
developed and tested.
Regardless of which method is used to evaluate a
diagnosis of dementia within a study, reporting requires
details regarding the domains that are tested, the rationale




Study diagnosis ▪ The most valid inclusion criterion if recommended
diagnostic procedures are followed
▪ Requires intense resources
▪ Burdens the resident
▪ Is ethically questionable in the nursing home population
▪ Decreases willingness to participate
Recorded diagnosis ▪ Requires little resources
▪ Easy and quick to assess
▪ No burden for the resident
▪ Increases willingness to participate
▪ Validity of the diagnosis cannot be assured
▪ Residents without a recorded diagnosis are systematically excluded
▪ Potential inclusion of false-positives
▪ Differential diagnosis is often missing
Recorded diagnosis
and screening result
▪ Requires little resources
▪ Easy and quick to assess
▪ No burden for the resident if proxy-ratings are used
▪ Increases willingness to participate if the resident is
not burdened with assessment procedures
▪ Validity of the diagnosis cannot thoroughly be assured, but with the
help of screening results false-positives can be detected and verified
▪ Residents without a recorded diagnosis are systematically excluded,
unless residents with a probable diagnosis are also screened and a
new diagnosis is evaluated
▪ Validity of the recorded diagnosis cannot be assured
▪ Differential diagnosis is often missing
Screening result ▪ Requires little resources
▪ Easy and quick to assess
▪ No burden for the resident if proxy-ratings are used
▪ Increases willingness to participate if the resident is
not burdened with assessment procedures
▪ The declaration of the existence of a dementia is not entirely possible
▪ Enables the selection of residents that are homogenous with regard
to the screened condition but cannot prevent heterogeneity of other
conditions
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behind instrument use for each domain examined, the
cutoff values set for each domain and the management
of missing data. Transparency in reporting missing data
is needed because approaches for adequately man-
aging these gaps can differ and produce varying effect
estimates [103].
If a dementia diagnosis is considered as dispensable or
a criteria-based diagnostic procedure cannot be applied
due to constrained resources, the study should not target
the dementia population, but instead clearly state which
population they are addressing.
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